ALX Oncology Announces Further Additions to Leadership Team and Board of Directors, Appointing Harish Shantharam as ...
Mr. Shantharam is a proven biotech industry executive with over two decades of senior leadership experience in finance, commercial and corporate operations Dr. Klencke is a seasoned clinical leader in oncology drug development with more than 20 years of …